APPLICATIONS PUBLISHED 29 DECEMBER 2004
Published: 14-Dec-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Administration form for oral administration of active ingredients, vitamins and/or nutrients
Gruenenthal 1490010*
System for orally administering active substances, vitamins and/or foodstuffs
Gruenenthal 1490011*
Drug signatures
Iconix Pharmaceuticals 1490023*
Effervescent compsns comprising bisphosphonates and methods related thereto
Lifizz 1490024*
Nanoparticulate compsns of MAP kinase inhibitors
Elan Pharma International 1490025*
Atomisable liposomes and their use for the pulmonary administration of active substances
Justus-Liebig-Universitaet Giessen 1490026*
Methods for entrapment of a bioactive agent in a liposome or lipid complex
Transave 1490027*
Delivery of a substance to a predetermined site
Applied NanoSystems 1490028*
Controlled release drug delivery system of pravastatin
Ranbaxy Laboratories 1490029*
Nanoparticulate compsns of angiogenesis inhibitors
Elan Pharma International 1490030*
Fast melt multiparticulate formulations for oral delivery
Vectura 1490031*
Processes for manufacturing polymeric microspheres
Boston Scientific 1490032*
NO-donating NSAIDS adsorbed into carrier particles
Nicox; AstraZeneca 1490033*
Novel pharmaceutical compsns for antihistaminic-decongestant combination and method of making such compsns
Dr Reddy's Laboratories 1490034*
Intraorally disintegrating valdecoxib compsns
Pharmacia Corp 1490035*
Sustained release formulation of tramadol
Cilag 1490036*
Taste masked veterinary solid compsns
Novartis 1490037*
Hybrid system for solubilising pharmaceutically active substances in polymer matrices
Beiersdorf 1490038*
Assembled unit consisting of individually separable transdermal therapeutic systems
Gruenenthal 1490039*
Anti-inflammatory formulations
Haines, David; Mahmoud, Fadia 1490040*
Treatment of female sexual dysfunction
Cst Medical 1490041*
Use of LTB4 antagonists in veterinary medicine
Boehringer Ingelheim Pharma 1490042*
Sprocyclic amides as cannabinoid receptor modulators
Merck 1490043*
Combination therapy for the treatment of conditions with pathogenic inflammatory components
Neurogen 1490044*
In vivo use of glutathionone S-transferase activated nitric oxide donors
University of Utah Research Foundation 1490045*
Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases
Vrabiescu, Alexandry 1490046*
Certain pharmaceutically useful substituted aminoalkyl heterocycles
SmithKline Beecham 1490047*
Pharmaceutical compsn for preventing or treating respiratory disease
Chugai Seiyaku KK 1490048*
Administration form for oral administration of active ingredients, vitamins and/or nutrients
Gruenenthal 1490010*
System for orally administering active substances, vitamins and/or foodstuffs
Gruenenthal 1490011*
Drug signatures
Iconix Pharmaceuticals 1490023*
Effervescent compsns comprising bisphosphonates and methods related thereto
Lifizz 1490024*
Nanoparticulate compsns of MAP kinase inhibitors
Elan Pharma International 1490025*
Atomisable liposomes and their use for the pulmonary administration of active substances
Justus-Liebig-Universitaet Giessen 1490026*
Methods for entrapment of a bioactive agent in a liposome or lipid complex
Transave 1490027*
Delivery of a substance to a predetermined site
Applied NanoSystems 1490028*
Controlled release drug delivery system of pravastatin
Ranbaxy Laboratories 1490029*
Nanoparticulate compsns of angiogenesis inhibitors
Elan Pharma International 1490030*
Fast melt multiparticulate formulations for oral delivery
Vectura 1490031*
Processes for manufacturing polymeric microspheres
Boston Scientific 1490032*
NO-donating NSAIDS adsorbed into carrier particles
Nicox; AstraZeneca 1490033*
Novel pharmaceutical compsns for antihistaminic-decongestant combination and method of making such compsns
Dr Reddy's Laboratories 1490034*
Intraorally disintegrating valdecoxib compsns
Pharmacia Corp 1490035*
Sustained release formulation of tramadol
Cilag 1490036*
Taste masked veterinary solid compsns
Novartis 1490037*
Hybrid system for solubilising pharmaceutically active substances in polymer matrices
Beiersdorf 1490038*
Assembled unit consisting of individually separable transdermal therapeutic systems
Gruenenthal 1490039*
Anti-inflammatory formulations
Haines, David; Mahmoud, Fadia 1490040*
Treatment of female sexual dysfunction
Cst Medical 1490041*
Use of LTB4 antagonists in veterinary medicine
Boehringer Ingelheim Pharma 1490042*
Sprocyclic amides as cannabinoid receptor modulators
Merck 1490043*
Combination therapy for the treatment of conditions with pathogenic inflammatory components
Neurogen 1490044*
In vivo use of glutathionone S-transferase activated nitric oxide donors
University of Utah Research Foundation 1490045*
Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases
Vrabiescu, Alexandry 1490046*
Certain pharmaceutically useful substituted aminoalkyl heterocycles
SmithKline Beecham 1490047*
Pharmaceutical compsn for preventing or treating respiratory disease
Chugai Seiyaku KK 1490048*
